खोज परिणाम - E. V. Lubennikova
- प्रदर्शित 1 - 2 परिणाम 2
-
1
Pharmacoeconomic analysis of using cyclin-dependent kinase 4 and 6 inhibitors in the first line treatment of HR-positive HER2-negative advanced breast cancer द्वारा N. A. Avxentyev, E. V. Lubennikova, M. Yu. Frolov
प्रकाशित 2020बोधानक: लोड हो रहा है…Connect to this object online.
स्थित: लोड हो रहा है…
पुस्तक -
2
Efficacy and safety of cisplatin and paclitaxel (PlaTax regimen) in the neoadjuvant treatment of patients with stage II-III triple-negative breast cancer द्वारा O. O. Gordeeva, I. V. Kolyadina, L. G. Zhukova, I. P. Ganshina, G. V. Vyshinskaya, M. A. Kazantseva, M. V. Sukhova, O. E. Ryabishina, E. V. Lubennikova, D. A. Filonenko, E. I. Chichikov, I. N. Polushkina, E. I. Borisova, A. N. Lud, A. A. Meshcheryakov
प्रकाशित 2020बोधानक: लोड हो रहा है…Connect to this object online.
स्थित: लोड हो रहा है…
पुस्तक